z-logo
open-access-imgOpen Access
The transcriptional repressor Bcl6 promotes pre-TCR induced differentiation to CD4+CD8+ thymocyte and attenuates Notch1 activation
Author(s) -
Anisha Solanki,
Diana C. Yánez,
ChingIn Lau,
Jasmine Rowell,
Alessandro Barbarulo,
Scott R. Ross,
Hemant Sahni,
Tessa Crompton
Publication year - 2020
Publication title -
development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.754
H-Index - 325
eISSN - 1477-9129
pISSN - 0950-1991
DOI - 10.1242/dev.192203
Subject(s) - biology , thymocyte , t cell receptor , bcl6 , cd8 , double negative , microbiology and biotechnology , t cell , cellular differentiation , transcription factor , population , notch signaling pathway , signal transduction , immunology , b cell , genetics , immune system , gene , germinal center , demography , sociology , antibody
Pre-TCR signal transduction is required for developing thymocytes to differentiate from CD4-CD8- double negative (DN) to CD4+CD8+ double positive (DP) cell. Notch signalling is required for T-cell fate specification and must be maintained throughout β-selection, but inappropriate Notch activation in DN4 and DP cells is oncogenic. Here, we show that pre-TCR signalling leads to increased expression of the transcriptional repressor Bcl6 and that Bcl6 is required for differentiation to DP. Conditional deletion of Bcl6 from thymocytes reduced pre-TCR-induced differentiation to DP cell, disrupted expansion and enrichment of icTCRβ+ cells within the DN population and increased DN4 cell death. It also increased Notch1 activation and Notch-mediated transcription in the DP population. Thus, Bcl6 is required in thymocyte development for efficient differentiation from DN3 to DP cell and to attenuate Notch1 activation in DP cells. Given the importance of inappropriate NOTCH1 signalling in T-ALL, and the involvement of Bcl6 in other types of leukaemia, this study is important to our understanding of T-ALL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here